Abstract:
If health impairments due to coronavirus disease 2019 (COVID-19) persist for 12 weeks or longer, patients are diagnosed with Post-COVID Syndrome (PCS), or Long-COVID. Although the COVID-19 pandemic has largely subsided in 2024, PCS is still a major health burden worldwide, and...
Background
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is associated with long-term disability and poor quality of life (QoL). Cardinal ME/CFS symptoms (including post-exertional malaise, cognitive dysfunction and sleep disturbances) have been observed in Post COVID-19 Condition...
cluster analysis
eaton-fitch
marshall-gradisnik
me/cfs
post-acute covid-19
post-acute sequelae of covid-19post-covidpost-covid19
quality of life
symptoms
Background
Many patients who recovered from COVID-19 still suffer from chronic fatigue syndrome (CFS). It was observed that patients with comorbidities were more prone to developing CFS. This research investigates the risk of post-COVID-19 CFS to assist healthcare professionals in reducing the...
Now published: link here
Preprint
Background: Post COVID-19 syndrome or Long Covid (LC) is a novel fluctuating condition with a protracted course in some patients. Specialist LC services have been operational in the UK since 2020 and deal with a high caseload of patients. Aims: To evaluate...
Highlights:
• Sleep complaints in PASC are frequent, varying from insomnia to excessive daytime sleepiness.
• Five categories of sleep disorders syndromes were identified in PASC: obstructive sleep apnea, insomnia, primary hypersomnia, REM behavior disorder (RBD), and new onset circadian phase...
Autoantibody helps with Long Covid
The German article
https://www.fau.de/2021/07/news/medikament-gegen-autoantikoerper-hilft-bei-long-covid/
The paper is most interesting because of microcirculation, plus the use of BC 007, originally a heart related drug, as a treatment...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.